OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable cryptotanshinone spray-dried swellable microparticles for pulmonary fibrosis therapy by regulating TGF-β1/Smad3, STAT3 and SIRT3 pathways
Xiuhua Wang, Wei Wan, Jing Lü, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 172, pp. 177-192
Closed Access | Times Cited: 15

Showing 15 citing articles:

Bioactive components and molecular mechanisms of Salvia miltiorrhiza Bunge in promoting blood circulation to remove blood stasis
Baoyu Wei, Chengtao Sun, Haitong Wan, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116697-116697
Closed Access | Times Cited: 43

Sirtuin family in autoimmune diseases
Zhengjie Tao, Zihan Jin, Jiabiao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25

P2Y12 receptor-independent antiplatelet mechanism of cryptotanshinone: network pharmacology and experimental validation of multi-target signaling pathways
Yi Xiao, Rui Zhang, Chaoying Hua, et al.
Journal of Ethnopharmacology (2025) Vol. 341, pp. 119321-119321
Closed Access | Times Cited: 1

Inhalable FN-binding liposomes or liposome-exosome hybrid bionic vesicles encapsulated microparticles for enhanced pulmonary fibrosis therapy
Xiuhua Wang, Wei Wan, Jing Lü, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124096-124096
Closed Access | Times Cited: 4

The Dual Roles of STAT3 in Ferroptosis: Mechanism, Regulation and Therapeutic Potential
Jinghui Xie, Dan Luo, Pengfei Xing, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4251-4266
Open Access

SIRT3/6/7: promising therapeutic targets for pulmonary fibrosis
Pingping Huang, Qin Du, Qin Yan-ling, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Mechanistic Insights Into the Role of Selenoprotein M in Nickel-Induced Lung Fibrosis
Haoyue Guan, Yue Sun, Senqiu Qiao, et al.
Biological Trace Element Research (2025)
Closed Access

Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis
Sara Ahmed, Mai Mansour, Rania A.H. Ishak, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123117-123117
Closed Access | Times Cited: 10

Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles
Xiuhua Wang, Wei Wan, Jiguo Zhang, et al.
Journal of Controlled Release (2023) Vol. 366, pp. 1-17
Closed Access | Times Cited: 8

Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress
Xiao-Xue Hou, Yuwen Li, Jiali Song, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 17, pp. 2616-2627
Open Access | Times Cited: 6

QbD driven targeted pulmonary delivery of dexamethasone-loaded chitosan microspheres: Biodistribution and pharmacokinetic study
B. Asha, Prakash Goudanavar, GSN Koteswara Rao, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101711-101711
Open Access | Times Cited: 5

Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma
Xuechun Wang, Gautam Chauhan, Alison R. L. Tacderas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5204-5204
Open Access | Times Cited: 4

Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation
Jiabin Liang, Lulu Cheng, Jie Feng, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4

Novel perspectives on the therapeutic role of cryptotanshinone in the management of stem cell behaviors for high-incidence diseases
Xiaomeng Guo, Ruishuang Ma, Meng Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 2

Page 1

Scroll to top